Pain Patch Market By Product Type (Non-Opioid Patches, Opioid Patches), By Type (Prescription Medicines, OTC Medicines), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031
The Pain Patches Market valued for $4,803.70 million in 2021 and is estimated to reach $7,338.07 million by 2031, exhibiting a CAGR of 4.3% from 2022 to 2031.
Pain patches are a transdermal method of pain relief that involves the application of medication to the skin, where it is absorbed into the bloodstream through the skin. These patches are designed to provide continuous, controlled release of medication over a period of time, which can help manage pain effectively. They are typically used for chronic pain conditions that require ongoing treatment, such as arthritis, back pain, and neuropathic pain. The medication can be either an opioid, such as fentanyl or buprenorphine, or a non-opioid, such as lidocaine or diclofenac. They are available as over the counter (OTC) products while most of these are available through prescription only.
The driving factor for pain patch market are increase in geriatric population, rise in usage of pain patches and increase in prevalence of chronic pain cases. For instance, according to U.S. Pain Foundation 2022 report, every year 50 million people suffer from chronic pain. Thus, rise in prevalence of chronic pain cases is expected to drive the growth of the market. In addition, the geriatric population is majorly prone to suffer from joint pain, neuropathic pain and other chronic pain conditions. Thus, rise in geriatric population potentially drives the market growth.
Furthermore, increase in awareness associated with advance method for pain management and availability of OTC pain patches products such as methyl salicylate and nitroglycerin are predicted to boost the growth of the market. In addition, rise in advancement in patches technology is anticipated to boost the market growth. Furthermore, many key players have adopted key strategies such as collaboration, business expansion, or alliance to increase their market presence in the global pain patch market. For instance, in August 2022, Sorrento Therapeutics Inc., announced that, ZTlido (lidocaine topical system) will be added to one of the largest National Pharmacy Benefit Managers (PBMs) and a national health plan – thereby expanding coverage to 30 million lives. Thus, such business expansions are expected to drive the growth of the market.
However, factors such as availability of alternative treatment such as acupuncture, physical therapy, and chiropractic care are projected to restrain the growth of the pain patch market. In addition, stringent government regulations associated with manufacturing and marketing of opioid-containing pain patches is expected to hamper the growth of the market.
The pain patch market is segmented into therapeutic class, type, distribution channel, and region. On the basis of therapeutic class, the market is bifurcated into non-opioids and opioids. The non-opioid segment is further categorized into nonsteroidal anti-inflammatory drugs (NSAIDS), methyl salicylate, lidocaine and others. The opioid segment is further categorized into buprenorphine and fentanyl. On the basis of type, the market is bifurcated into prescription medicines and OTC medicines. On the basis of distribution channel, the market is segregated into hospital pharmacies, drug stores and retail pharmacies and online providers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global pain patch market are NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P., Amneal Pharmaceuticals LLC, and Grunenthal .
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pain patch market analysis from 2021 to 2031 to identify the prevailing pain patch market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the pain patch market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global pain patch market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Non-Opioid Patches
Drugs
Nonsteroidal Anti-Inflammatory Drugs
Methyl Salicylate
Lidocaine
Others
Opioid Patches
Drugs
Buprenorphine
Fentanyl
By Type
Prescription Medicines
OTC Medicines
By Distribution Channel
Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Providers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd.
Sorrento Therapeutics Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Technological advancement in pain patches
- 3.4.1.2. Rise in prevalence of Chronic Pain
- 3.4.1.3. Rising adoption of pain patch for pain management
- 3.4.2. Restraints
- 3.4.2.1. Availability of alternate treatments
- 3.4.2.2. Stringent government regulations
- 3.4.3. Opportunities
- 3.4.3.1. Growth opportunities in emerging markets
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: PAIN PATCH MARKET, BY PRODUCT TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Non-Opioid Patches
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Non-Opioid Patches Pain Patch Market by Drugs
- 4.3. Opioid Patches
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Opioid Patches Pain Patch Market by Drugs
- CHAPTER 5: PAIN PATCH MARKET, BY TYPE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Prescription Medicines
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. OTC Medicines
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospital Pharmacies
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Drug Stores and Retail Pharmacies
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Online Providers
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: PAIN PATCH MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product Type
- 7.2.3. Market size and forecast, by Type
- 7.2.4. Market size and forecast, by Distribution Channel
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Product Type
- 7.2.5.1.3. Market size and forecast, by Type
- 7.2.5.1.4. Market size and forecast, by Distribution Channel
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Product Type
- 7.2.5.2.3. Market size and forecast, by Type
- 7.2.5.2.4. Market size and forecast, by Distribution Channel
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Product Type
- 7.2.5.3.3. Market size and forecast, by Type
- 7.2.5.3.4. Market size and forecast, by Distribution Channel
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product Type
- 7.3.3. Market size and forecast, by Type
- 7.3.4. Market size and forecast, by Distribution Channel
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Product Type
- 7.3.5.1.3. Market size and forecast, by Type
- 7.3.5.1.4. Market size and forecast, by Distribution Channel
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Product Type
- 7.3.5.2.3. Market size and forecast, by Type
- 7.3.5.2.4. Market size and forecast, by Distribution Channel
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Product Type
- 7.3.5.3.3. Market size and forecast, by Type
- 7.3.5.3.4. Market size and forecast, by Distribution Channel
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Product Type
- 7.3.5.4.3. Market size and forecast, by Type
- 7.3.5.4.4. Market size and forecast, by Distribution Channel
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Product Type
- 7.3.5.5.3. Market size and forecast, by Type
- 7.3.5.5.4. Market size and forecast, by Distribution Channel
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Product Type
- 7.3.5.6.3. Market size and forecast, by Type
- 7.3.5.6.4. Market size and forecast, by Distribution Channel
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product Type
- 7.4.3. Market size and forecast, by Type
- 7.4.4. Market size and forecast, by Distribution Channel
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Product Type
- 7.4.5.1.3. Market size and forecast, by Type
- 7.4.5.1.4. Market size and forecast, by Distribution Channel
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Product Type
- 7.4.5.2.3. Market size and forecast, by Type
- 7.4.5.2.4. Market size and forecast, by Distribution Channel
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Product Type
- 7.4.5.3.3. Market size and forecast, by Type
- 7.4.5.3.4. Market size and forecast, by Distribution Channel
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Product Type
- 7.4.5.4.3. Market size and forecast, by Type
- 7.4.5.4.4. Market size and forecast, by Distribution Channel
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Product Type
- 7.4.5.5.3. Market size and forecast, by Type
- 7.4.5.5.4. Market size and forecast, by Distribution Channel
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Product Type
- 7.4.5.6.3. Market size and forecast, by Type
- 7.4.5.6.4. Market size and forecast, by Distribution Channel
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product Type
- 7.5.3. Market size and forecast, by Type
- 7.5.4. Market size and forecast, by Distribution Channel
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Product Type
- 7.5.5.1.3. Market size and forecast, by Type
- 7.5.5.1.4. Market size and forecast, by Distribution Channel
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Product Type
- 7.5.5.2.3. Market size and forecast, by Type
- 7.5.5.2.4. Market size and forecast, by Distribution Channel
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Product Type
- 7.5.5.3.3. Market size and forecast, by Type
- 7.5.5.3.4. Market size and forecast, by Distribution Channel
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Product Type
- 7.5.5.4.3. Market size and forecast, by Type
- 7.5.5.4.4. Market size and forecast, by Distribution Channel
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
- CHAPTER 9: COMPANY PROFILES
- 9.1. Viatris Inc.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.2. Johnson and Johnson
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.3. Teva Pharmaceutical Industries Ltd.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.3.7. Key strategic moves and developments
- 9.4. Hisamitsu Pharmaceutical Co.,Inc.
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
- 9.5. Endo International plc.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.6. NEXGEL Advanced Hydrogel Solutions
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.7. Purdue Pharma L.P.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.8. Sorrento Therapeutics Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Key strategic moves and developments
- 9.9. Amneal Pharmaceuticals LLC
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.9.7. Key strategic moves and developments
- 9.10. Grunenthal
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 02. PAIN PATCH MARKET FOR NON-OPIOID PATCHES, BY REGION, 2021-2031 ($MILLION)
- TABLE 03. GLOBAL NON-OPIOID PATCHES PAIN PATCH MARKET, BY DRUGS, 2021-2031 ($MILLION)
- TABLE 04. PAIN PATCH MARKET FOR OPIOID PATCHES, BY REGION, 2021-2031 ($MILLION)
- TABLE 05. GLOBAL OPIOID PATCHES PAIN PATCH MARKET, BY DRUGS, 2021-2031 ($MILLION)
- TABLE 06. GLOBAL PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 07. PAIN PATCH MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 08. PAIN PATCH MARKET FOR OTC MEDICINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 09. GLOBAL PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 10. PAIN PATCH MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. PAIN PATCH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. PAIN PATCH MARKET FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. PAIN PATCH MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. NORTH AMERICA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 15. NORTH AMERICA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 16. NORTH AMERICA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 17. NORTH AMERICA PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 18. U.S. PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 19. U.S. PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 20. U.S. PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 21. CANADA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 22. CANADA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 23. CANADA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 24. MEXICO PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 25. MEXICO PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 26. MEXICO PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 27. EUROPE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 28. EUROPE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 29. EUROPE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 30. EUROPE PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 31. GERMANY PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 32. GERMANY PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 33. GERMANY PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 34. FRANCE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 35. FRANCE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 36. FRANCE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 37. UK PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 38. UK PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 39. UK PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 40. ITALY PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 41. ITALY PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 42. ITALY PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 43. SPAIN PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 44. SPAIN PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 45. SPAIN PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 46. REST OF EUROPE PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 47. REST OF EUROPE PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 48. REST OF EUROPE PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 49. ASIA-PACIFIC PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 50. ASIA-PACIFIC PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 51. ASIA-PACIFIC PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 52. ASIA-PACIFIC PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 53. JAPAN PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 54. JAPAN PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 55. JAPAN PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 56. CHINA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 57. CHINA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 58. CHINA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 59. INDIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 60. INDIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 61. INDIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 62. AUSTRALIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 63. AUSTRALIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 64. AUSTRALIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 65. SOUTH KOREA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 66. SOUTH KOREA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 67. SOUTH KOREA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 70. REST OF ASIA-PACIFIC PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 71. LAMEA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 72. LAMEA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 73. LAMEA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 74. LAMEA PAIN PATCH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 75. BRAZIL PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 76. BRAZIL PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 77. BRAZIL PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 78. SAUDI ARABIA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 79. SAUDI ARABIA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 80. SAUDI ARABIA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 81. SOUTH AFRICA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 82. SOUTH AFRICA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 83. SOUTH AFRICA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 84. REST OF LAMEA PAIN PATCH MARKET, BY PRODUCT TYPE, 2021-2031 ($MILLION)
- TABLE 85. REST OF LAMEA PAIN PATCH MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 86. REST OF LAMEA PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
- TABLE 87. VIATRIS INC.: KEY EXECUTIVES
- TABLE 88. VIATRIS INC.: COMPANY SNAPSHOT
- TABLE 89. VIATRIS INC.: PRODUCT SEGMENTS
- TABLE 90. VIATRIS INC.: PRODUCT PORTFOLIO
- TABLE 91. JOHNSON AND JOHNSON: KEY EXECUTIVES
- TABLE 92. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 93. JOHNSON AND JOHNSON: PRODUCT SEGMENTS
- TABLE 94. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 95. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
- TABLE 96. TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
- TABLE 97. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT SEGMENTS
- TABLE 98. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
- TABLE 99. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATERGIES
- TABLE 100. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY EXECUTIVES
- TABLE 101. HISAMITSU PHARMACEUTICAL CO.,INC.: COMPANY SNAPSHOT
- TABLE 102. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT SEGMENTS
- TABLE 103. HISAMITSU PHARMACEUTICAL CO.,INC.: PRODUCT PORTFOLIO
- TABLE 104. HISAMITSU PHARMACEUTICAL CO.,INC.: KEY STRATERGIES
- TABLE 105. ENDO INTERNATIONAL PLC.: KEY EXECUTIVES
- TABLE 106. ENDO INTERNATIONAL PLC.: COMPANY SNAPSHOT
- TABLE 107. ENDO INTERNATIONAL PLC.: PRODUCT SEGMENTS
- TABLE 108. ENDO INTERNATIONAL PLC.: PRODUCT PORTFOLIO
- TABLE 109. NEXGEL ADVANCED HYDROGEL SOLUTIONS: KEY EXECUTIVES
- TABLE 110. NEXGEL ADVANCED HYDROGEL SOLUTIONS: COMPANY SNAPSHOT
- TABLE 111. NEXGEL ADVANCED HYDROGEL SOLUTIONS: PRODUCT SEGMENTS
- TABLE 112. NEXGEL ADVANCED HYDROGEL SOLUTIONS: PRODUCT PORTFOLIO
- TABLE 113. PURDUE PHARMA L.P.: KEY EXECUTIVES
- TABLE 114. PURDUE PHARMA L.P.: COMPANY SNAPSHOT
- TABLE 115. PURDUE PHARMA L.P.: PRODUCT SEGMENTS
- TABLE 116. PURDUE PHARMA L.P.: PRODUCT PORTFOLIO
- TABLE 117. SORRENTO THERAPEUTICS INC.: KEY EXECUTIVES
- TABLE 118. SORRENTO THERAPEUTICS INC.: COMPANY SNAPSHOT
- TABLE 119. SORRENTO THERAPEUTICS INC.: PRODUCT SEGMENTS
- TABLE 120. SORRENTO THERAPEUTICS INC.: PRODUCT PORTFOLIO
- TABLE 121. SORRENTO THERAPEUTICS INC.: KEY STRATERGIES
- TABLE 122. AMNEAL PHARMACEUTICALS LLC: KEY EXECUTIVES
- TABLE 123. AMNEAL PHARMACEUTICALS LLC: COMPANY SNAPSHOT
- TABLE 124. AMNEAL PHARMACEUTICALS LLC: PRODUCT SEGMENTS
- TABLE 125. AMNEAL PHARMACEUTICALS LLC: PRODUCT PORTFOLIO
- TABLE 126. AMNEAL PHARMACEUTICALS LLC: KEY STRATERGIES
- TABLE 127. GRUNENTHAL: KEY EXECUTIVES
- TABLE 128. GRUNENTHAL: COMPANY SNAPSHOT
- TABLE 129. GRUNENTHAL: PRODUCT SEGMENTS
- TABLE 130. GRUNENTHAL: PRODUCT PORTFOLIO
- TABLE 131. GRUNENTHAL: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. PAIN PATCH MARKET, 2021-2031
- FIGURE 02. SEGMENTATION OF PAIN PATCH MARKET, 2021-2031
- FIGURE 03. TOP INVESTMENT POCKETS IN PAIN PATCH MARKET (2022-2031)
- FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05. LOW BARGAINING POWER OF BUYERS
- FIGURE 06. LOW THREAT OF SUBSTITUTES
- FIGURE 07. LOW THREAT OF NEW ENTRANTS
- FIGURE 08. LOW INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALPAIN PATCH MARKET
- FIGURE 10. PAIN PATCH MARKET, BY PRODUCT TYPE, 2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR NON-OPIOID PATCHES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR OPIOID PATCHES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 13. PAIN PATCH MARKET, BY TYPE, 2021(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR OTC MEDICINES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 16. PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2021(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR HOSPITAL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PAIN PATCH MARKET FOR ONLINE PROVIDERS, BY COUNTRY 2021 AND 2031(%)
- FIGURE 20. PAIN PATCH MARKET BY REGION, 2021
- FIGURE 21. U.S. PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 22. CANADA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 23. MEXICO PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 24. GERMANY PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 25. FRANCE PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 26. UK PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 27. ITALY PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 28. SPAIN PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 29. REST OF EUROPE PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 30. JAPAN PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 31. CHINA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 32. INDIA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 33. AUSTRALIA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 34. SOUTH KOREA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 35. REST OF ASIA-PACIFIC PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 36. BRAZIL PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 37. SAUDI ARABIA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 38. SOUTH AFRICA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 39. REST OF LAMEA PAIN PATCH MARKET, 2021-2031 ($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44. COMPETITIVE DASHBOARD
- FIGURE 45. COMPETITIVE HEATMAP: PAIN PATCH MARKET
- FIGURE 46. TOP PLAYER POSITIONING, 2021
- FIGURE 47. VIATRIS INC.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 48. VIATRIS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 49. JOHNSON AND JOHNSON: SALES REVENUE, 2019-2021 ($MILLION)
- FIGURE 50. JOHNSON AND JOHNSON: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 51. JOHNSON AND JOHNSON: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 52. TEVA PHARMACEUTICAL INDUSTRIES LTD.: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 53. TEVA PHARMACEUTICAL INDUSTRIES LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 54. HISAMITSU PHARMACEUTICAL CO.,INC.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 55. ENDO INTERNATIONAL PLC.: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 56. ENDO INTERNATIONAL PLC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 57. AMNEAL PHARMACEUTICALS LLC: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 58. AMNEAL PHARMACEUTICALS LLC: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 59. GRUNENTHAL: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 60. GRUNENTHAL: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 61. GRUNENTHAL: REVENUE SHARE BY REGION, 2021 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook